Puma Biotechnology
PBYI
PBYI
104 hedge funds and large institutions have $85.9M invested in Puma Biotechnology in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 26 increasing their positions, 41 reducing their positions, and 17 closing their positions.
Holders
104
Holders Change
+2
Holders Change %
+1.96%
% of All Funds
1.65%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
20
Increased
26
Reduced
41
Closed
17
Calls
$211K
Puts
$573K
Net Calls
-$362K
Net Calls Change
-$568K
Top Buyers
1 |
CCM
1
Camber Capital Management
Boston,
Massachusetts
|
$11.5M |
2 |
ACM
2
Athyrium Capital Management
New York
|
$5.16M |
3 |
EP
3
Eversept Partners
New York
|
$4.1M |
4 |
4
D.E. Shaw & Co
New York
|
$2.9M |
5 |
5
Millennium Management
New York
|
$5.51M |